{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:10:20Z","timestamp":1792015820038,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007231","name":"Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.pathol.2024.12.633","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:15:00Z","timestamp":1737159300000},"page":"293-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gleason scores provide more accurate prognostic information than grade groups"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8531-222X","authenticated-orcid":false,"given":"Lars","family":"Egevad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Micoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Delahunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5796-1791","authenticated-orcid":false,"given":"Hemamali","family":"Samaratunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Garmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5032-5266","authenticated-orcid":false,"given":"Martin","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2024.12.633_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.12.633_bib2","series-title":"Urinary and male genital tumours","year":"2022"},{"issue":"3","key":"10.1016\/j.pathol.2024.12.633_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A\u00a0contemporary prostate cancer grading system: a validated alternative to the Gleason score","volume":"69","author":"Epstein","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bju.15298","article-title":"Prostate cancer grading, time to go back to the future","volume":"127","author":"Egevad","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2024.12.633_bib5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00428-024-03810-y","article-title":"Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study","volume":"484","author":"Egevad","year":"2024","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2024.12.633_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.euo.2023.11.002","article-title":"Prognosis of Gleason score 9-10 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study","volume":"7","author":"Egevad","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.pathol.2024.12.633_bib7","first-page":"1076","article-title":"Outcome of Gleason 3+5=8 prostate cancer diagnosed on needle biopsy: prognostic comparison with Gleason 4+4=8","volume":"196","author":"Harding-Jackson","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.eururo.2015.08.054","article-title":"Gleason score 3+5 or 5+3 versus 4+4 prostate cancer: the risk of death","volume":"69","author":"Huynh","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s12253-017-0331-2","article-title":"ISUP Group 4 - a homogenous group of prostate cancers?","volume":"24","author":"Lu","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.pathol.2024.12.633_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bju.13478","article-title":"Validation of the novel International Society of Urological Pathology 2014 five-tier Gleason grade grouping: biochemical recurrence rates for 3+5 disease may be overestimated","volume":"118","author":"van den Bergh","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2024.12.633_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eururo.2012.08.001","article-title":"Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study","volume":"63","author":"Rider","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0090-4295(00)00791-3","article-title":"Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival","volume":"56","author":"Sakr","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2024.12.633_bib13","series-title":"Pathology and genetics of tumours of the urinary system and male genital organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.pathol.2024.12.633_bib14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00428-006-0310-6","article-title":"The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens","volume":"449","author":"Helpap","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2024.12.633_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/jama.281.15.1395","article-title":"Biological determinants of cancer progression in men with prostate cancer","volume":"281","author":"Stamey","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2024.12.633_bib16","first-page":"509","article-title":"Percent Gleason grade 4\/5 as prognostic factor in prostate cancer diagnosed at transurethral resection","volume":"168","author":"Egevad","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","article-title":"Clinical utility of quantitative Gleason\u00a0grading\u00a0in prostate biopsies and prostatectomy specimens","volume":"69","author":"Sauter","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pathol.2021.11.004","article-title":"Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial","volume":"54","author":"Delahunt","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2024.12.633_bib19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/1097-0142(19900915)66:6<1225::AID-CNCR2820660624>3.0.CO;2-X","article-title":"Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate","volume":"66","author":"McNeal","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2024.12.633_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2024.01.005","article-title":"Amount of Gleason pattern 3 is not predictive of risk in grade group 2-4 prostate cancer","volume":"86","author":"Vickers","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib21","first-page":"664","article-title":"Interobserver reproducibility of percent Gleason grade 4\/5 in prostate biopsies","volume":"171","author":"Glaessgen","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1470-2045(19)30738-7","article-title":"Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study","volume":"21","author":"Strom","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2024.12.633_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/bju.12671","article-title":"Gleason inflation 1998-2011: a registry study of 97,168 men","volume":"115","author":"Danneman","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2024.12.633_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.12.633_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN guidelines insights: prostate cancer, version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.pathol.2024.12.633_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2019.11.002","article-title":"Gleason score 5+3=8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading","volume":"97","author":"Kryvenko","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2024.12.633_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cam4.3571","article-title":"Differences in survival of prostate cancer Gleason 8-10 disease and the establishment of a new Gleason survival grading system","volume":"10","author":"Zhou","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.pathol.2024.12.633_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(94)80264-5","article-title":"Heterogeneity of prostate cancer in radical prostatectomy specimens","volume":"43","author":"Aihara","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2024.12.633_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humpath.2004.10.001","article-title":"Epstein JI. Current practice of Gleason grading among genitourinary pathologists","volume":"36","author":"Egevad","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2024.12.633_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00428-019-02574-0","article-title":"Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting","volume":"475","author":"Kench","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2024.12.633_bib32","first-page":"1695","article-title":"Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma","volume":"175","author":"Hattab","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000478-200004000-00011","article-title":"The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system","volume":"24","author":"Pan","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.12.633_bib34","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/cncr.20243","article-title":"Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate","volume":"100","author":"Arora","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2024.12.633_bib35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/bjc.2016.86","article-title":"Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome","volume":"114","author":"Berney","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2024.12.633_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.humpath.2008.07.020","article-title":"Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?","volume":"40","author":"Kunju","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2024.12.633_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2490-11-21","article-title":"Overall and worst gleason scores are equally good predictors of prostate cancer progression","volume":"11","author":"Tolonen","year":"2011","journal-title":"BMC Urol"},{"key":"10.1016\/j.pathol.2024.12.633_bib38","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000001137","article-title":"Concordance of \"case level\" global, highest, and largest volume cancer grade group on needle biopsy versus grade group on radical prostatectomy","volume":"42","author":"Trpkov","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2024.12.633_bib39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/his.13427","article-title":"Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3+4=7 and highest Gleason score 3+4=7 or > 3+4=7","volume":"72","author":"Verhoef","year":"2018","journal-title":"Histopathology"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:07:23Z","timestamp":1741208843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302525000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0031302525000364"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2024.12.633","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gleason scores provide more accurate prognostic information than grade groups","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2024.12.633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.","name":"copyright","label":"Copyright"}]}}